NDC 70710-2007-03 - Deflazacort Oral Suspension

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70710-2007
Requested NDC
70710-2007-03
Package NDCs from labels
70710-2007-3, 70710-2007-03
Manufacturer
Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l.
Effective date
2026-11-05
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Deflazacort Oral SuspensionZydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l.2026-11-05HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70710-2007-3Deflazacort Oral Suspension13 mL in 1 BOTTLESUSPENSION132
70710-2007-3Deflazacort Oral Suspension1 in 1 CARTONSUSPENSION12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70710-2007-3ML - Milliliter70710-200740ccc302-cbc6-450e-8d85-a62dcaa8638812026-01-08

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 10 · 195 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Deflazacort Oral SuspensionDEFLAZACORTZydus Pharmaceuticals (USA) Inc.14569f71-573e-49fd-b80e-b3b52531b1c82026-11-05Warnings, Adverse reactionsExact identifier
application number: ANDA220042
ndc (package): 70710-2007-3
ndc (product): 70710-2007
ndc11 (package): 70710200703
rxcui: 1870964
spl id: 530bac01-4487-43bb-a9b4-62ada9166a49
spl set id: 14569f71-573e-49fd-b80e-b3b52531b1c8
unii: KR5YZ6AE4B
JAYTHARI Oral SuspensionDEFLAZACORTZydus Pharmaceuticals (USA) Inc.abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa92026-11-05Warnings, Adverse reactionsExact identifier
application number: ANDA220042
rxcui: 1870964
unii: KR5YZ6AE4B
FUNGAL NAIL TREATMENTGLACIAL ACETIC ACIDGuchutang Biotechnology (Longyan) Co., Ltd5efd832a-e362-c8dd-e063-6294a90a107c2026-10-29WarningsExact identifier
unii: Q40Q9N063P
BACTERIOSTATICWATERElementco, S.A.P.I. de C.V.5e7465d8-dbe4-2f86-e063-6394a90a8dfb2026-10-23WarningsExact identifier
unii: LKG8494WBH
Rohto Max StrengthNAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80The Mentholatum Companye4b49550-1ca3-4bd7-854d-409b53fa5e262026-10-16WarningsExact identifier
unii: 6OZP39ZG8H
TheraTears ExtraCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMMEDTECH PRODUCTS INC77f504c1-b8e0-4371-ac3e-9d453d84714b2026-10-15WarningsExact identifier
unii: K679OBS311
TheraTears ExtraCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDMEDTECH PRODUCTS INCf1845041-9d8d-42a0-a2cb-68def7a5aac72026-10-15WarningsExact identifier
unii: K679OBS311
TheraTears LubricantCARBOXYMETHYLCELLULOSE SODIUMMEDTECH PRODUCTS INC797b0394-2f0f-4733-8d20-ec5bdf3e085d2026-10-15WarningsExact identifier
unii: K679OBS311
EMFLAZADEFLAZACORTPTC Therapeutics, Inc.31b347d2-f156-4055-9d8f-7cf0df4202962026-10-13Warnings, Adverse reactionsExact identifier
rxcui: 1870964
unii: KR5YZ6AE4B
VitaPhyte Lubricant Eye DropsLUBRICANT EYE DROPSGuangzhou Liyan Cosmetics Technology Co., Ltd.5d39f7b1-c0ed-33dc-e063-6394a90aee312026-10-07WarningsExact identifier
unii: K679OBS311
DeflazacortDEFLAZACORTHikma Pharmaceuticals USA Inc.00df3169-b8e3-4584-823b-91b71807d1a62026-10-07Warnings, Adverse reactionsExact identifier
unii: KR5YZ6AE4B
VitaPhyte Lubricating Eye DropsLUBRICATING EYE DROPSGuangzhou Liyan Cosmetics Technology Co., Ltd.5c6360a4-6fd9-f5f6-e063-6294a90a8e612026-09-26WarningsExact identifier
unii: K679OBS311
TheraTearsCARBOXYMETHYLCELLULOSE SODIUMMEDTECH PRODUCTS INC17a01236-130f-495b-9f8d-92b6a23b2dc52026-09-09WarningsExact identifier
unii: K679OBS311
Deflazacort Oral SuspensionDEFLAZACORT ORALBiocon Pharma Inc.e76f35a5-711c-c511-9fd8-b8c4c0b43b852026-08-31Warnings, Adverse reactionsExact identifier
rxcui: 1870964
unii: KR5YZ6AE4B
REFRESH LIQUIGELCARBOXYMETHYLCELLULOSE SODIUMAllergan, Inc.4b8b2f6a-4b89-446c-9e5b-9b83c453a01d2026-08-28WarningsExact identifier
unii: K679OBS311
DeflazacortDEFLAZACORTDoppel Farmaceutici S.r.l.34a03eb7-74f5-4471-e063-6394a90aca632026-08-27Warnings, Adverse reactionsExact identifier
unii: KR5YZ6AE4B
JAYTHARIDEFLAZACORTDoppel Farmaceutici S.r.l.3542a1e3-acfd-6b9a-e063-6394a90a94662026-08-27Warnings, Adverse reactionsExact identifier
unii: KR5YZ6AE4B
0.9% Benzyl Alcohol Solution (Laboratory Use Only)0.9% BENZYL ALCOHOL SOLUTION (LABORATORY USE ONLY)Guangzhou Huanmei Cosmetics Co., Ltd5976bde6-0999-ffc4-e063-6394a90aadcf2026-08-20WarningsExact identifier
unii: LKG8494WBH
Deflazacort Oral SuspensionDEFLAZACORT ORALSun Pharmaceutical Industries, Inc.2fac1332-0247-1047-e063-6294a90a557f2026-08-13Warnings, Adverse reactionsExact identifier
rxcui: 1870964
unii: KR5YZ6AE4B
Lipo-ChordACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM.Energetix Corporation5c83cbd5-46fb-48a0-a739-ff9c81e7129c2026-08-11WarningsExact identifier
unii: Q40Q9N063P

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.